Compare SRRK & KGS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SRRK | KGS |
|---|---|---|
| Founded | 2012 | 2011 |
| Country | United States | United States |
| Employees | 289 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.8B | 7.7B |
| IPO Year | 2018 | 2023 |
| Metric | SRRK | KGS |
|---|---|---|
| Price | $56.97 | $67.77 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 13 | 7 |
| Target Price | $56.17 | ★ $57.17 |
| AVG Volume (30 Days) | 1.5M | ★ 1.8M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 2.93% |
| EPS Growth | N/A | ★ 58.93 |
| EPS | N/A | ★ 0.20 |
| Revenue | N/A | ★ $1,308,100,000.00 |
| Revenue This Year | N/A | $12.30 |
| Revenue Next Year | $534.24 | $7.96 |
| P/E Ratio | ★ N/A | $336.05 |
| Revenue Growth | N/A | ★ 12.83 |
| 52 Week Low | $27.07 | $30.06 |
| 52 Week High | $58.12 | $77.68 |
| Indicator | SRRK | KGS |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 45.87 |
| Support Level | $41.38 | $65.10 |
| Resistance Level | N/A | $77.13 |
| Average True Range (ATR) | 2.45 | 3.24 |
| MACD | 0.52 | -0.54 |
| Stochastic Oscillator | 85.32 | 19.11 |
Scholar Rock Holding Corp is a biopharmaceutical company focused on improving the lives of children and adults with Spinal Muscular Atrophy and other rare, severe, and debilitating neuromuscular diseases. Its pipeline candidates include apitegromab and a subcutaneous formulation of apitegromab. The clinical-stage pipeline also includes SRK-439, an investigational subcutaneously administered fully human anti-pro/latent myostatin antibody with high inhibitory potency and selectivity toward myostatin, being developed for the treatment of rare neuromuscular diseases. The company also maintains early-stage programs focused on therapies for rare, severe, and debilitating neuromuscular diseases.
Kodiak Gas Services Inc is an operator of contract compression infrastructure in the United States. The company manages its business through two operating segments: Contract Services and Other Services. Contract Services consists of operating company-owned and customer-owned compression, gas treating, and cooling infrastructure, pursuant to fixed-revenue contracts to enable the production and gathering of natural gas and oil. Other Services consist of a full range of contract services to support the ancillary needs of customers, including station construction, maintenance and overhaul, freight and crane charges, and other time and material-based offerings. Maximum revenue for the company is generated from its Contract Services segment.